New hope for tough stomach tumors: experimental drug combo enters human testing
NCT ID NCT06655246
Summary
This early-stage trial is testing the safety and initial effectiveness of a new oral drug, ziftomenib, when given alongside the standard drug imatinib. It is for adults with advanced gastrointestinal stromal tumors (GIST) whose cancer has continued to grow despite treatment with imatinib alone. The main goals are to find a safe dose and see if the combination can help control the cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GASTROINTESTINAL STROMAL TUMOR (GIST) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Duke University Medical Center
RECRUITINGDurham, North Carolina, 27710, United States
-
Harvard University
RECRUITINGBoston, Massachusetts, 02215, United States
-
Johns Hopkins University
RECRUITINGBaltimore, Maryland, 21287, United States
-
Massachusetts General Hospital
RECRUITINGBoston, Massachusetts, 02114, United States
-
Mayo Clinic Cancer Center
RECRUITINGPhoenix, Arizona, 85054, United States
-
Mayo Clinic Cancer Center
RECRUITINGJacksonville, Florida, 32224, United States
-
Mayo Clinic Cancer Center
RECRUITINGRochester, Minnesota, 55905, United States
-
Medical College of Wisconsin
RECRUITINGMilwaukee, Wisconsin, 53226, United States
-
Memorial Sloan-Kettering Cancer Center
RECRUITINGNew York, New York, 10065, United States
-
Northwestern University
RECRUITINGChicago, Illinois, 60611, United States
-
Ohio State University
RECRUITINGColumbus, Ohio, 43210, United States
-
Oregon Health & Science University
RECRUITINGPortland, Oregon, 97239, United States
-
Sarah Cannon Research Institute
RECRUITINGDenver, Colorado, 80220, United States
-
Sarah Cannon Research Institute
RECRUITINGNashville, Tennessee, 37203, United States
-
Sarah Cannon Research Institute
RECRUITINGDallas, Texas, 75230, United States
-
Stanford Cancer Institute
RECRUITINGPalo Alto, California, 94304, United States
-
Temple University Health System
RECRUITINGPhiladelphia, Pennsylvania, 19111, United States
-
Thomas Jefferson University
RECRUITINGPhiladelphia, Pennsylvania, 19107, United States
-
UCLA Santa Monica Medical Center
RECRUITINGSanta Monica, California, 90404, United States
-
University Of California, Irvine
RECRUITINGOrange, California, 92868, United States
-
University of Alabama at Birmingham
RECRUITINGBirmingham, Alabama, 35233, United States
-
University of California, San Diego
RECRUITINGLa Jolla, California, 92093, United States
-
University of Colorado Cancer Center
RECRUITINGAurora, Colorado, 80045, United States
-
University of Iowa
RECRUITINGIowa City, Iowa, 52242, United States
-
University of Miami
RECRUITINGMiami, Florida, 33136, United States
-
University of Michigan
RECRUITINGAnn Arbor, Michigan, 48109, United States
-
University of Southern California
RECRUITINGLos Angeles, California, 90033, United States
-
University of Texas
RECRUITINGHouston, Texas, 77030, United States
-
University of Texas Health Science Center
RECRUITINGSan Antonio, Texas, 78229, United States
-
University of Utah
RECRUITINGSalt Lake City, Utah, 84112, United States
-
Vanderbilt University Medical Center
RECRUITINGNashville, Tennessee, 37232, United States
-
Yale University School of Medicine
RECRUITINGNew Haven, Connecticut, 06511, United States
Conditions
Explore the condition pages connected to this study.